AI BDR for Pharmaceutical Companies — Autonomous Outbound
Strides Agent helps pharmaceutical companies and pharma technology vendors reach medical affairs teams, procurement, and R&D leaders. AI outbound for pharma pipeline.
Pharmaceutical B2B sales requires deep domain knowledge and perfect timing. Strides monitors pipeline milestones, regulatory events, and funding activity to reach pharma buyers at exactly the right moment.
By the Numbers
- 4.7× — More pharma meetings booked
- 12–24mo — Sales cycles Strides manages
- 0 — SDR headcount required
- 48h — From FDA event to first outreach
Built for Pharma and Life Sciences Sales.
Clinical milestone monitoring, procurement targeting, and autonomous outreach calibrated for pharmaceutical industry buyers.
Prospect Research
Finds, scores, and qualifies your ideal customers from 6 live data sources — hiring signals, funding rounds, intent data, and more.
Personalized Outreach
Writes and sends emails that reference the prospect's specific context. Not templates with merge fields — genuinely unique messages for every person.
AI Phone Calls
Real phone conversations with real objection handling. The AI books meetings on the call, detects voicemail in 2 seconds, and leaves a perfect message every time.
Inbound Handling
Responds to every inbound inquiry in under 60 seconds, qualifies them against your ICP, and books a meeting before your team even opens their laptop.
Autonomous Pipeline
Stranger to booked meeting without a single human touchpoint. The full outbound motion runs on its own, 24/7, across every timezone.
CRM Sync & Reporting
Every interaction logged to your CRM automatically. Calls transcribed, scored, and summarized. Full pipeline visibility without any manual data entry.
Pharmaceutical B2B Outbound Requires Domain Knowledge and Precise Timing
Pharmaceutical companies are among the most complex B2B buyers. Procurement decisions involve multiple stakeholders across medical affairs, R&D, manufacturing, regulatory, and commercial functions. Reaching the right person with the right message requires genuine understanding of drug development processes, regulatory milestones, and the specific stage of each company's pipeline.
The signals that trigger pharma B2B purchasing decisions are well-defined: FDA approval events (triggering commercial launch infrastructure needs), IND filings (indicating early-stage CRO and CMO needs), Phase II/III initiations (creating CRO capacity needs), and manufacturing scale-up announcements (triggering CMO and supply chain procurement).
Pharma companies and pharma technology vendors using Strides see the most impact in systematic vendor relationship development — particularly CROs, CDMOs, lab supply companies, and clinical technology vendors — where the prospect universe is manageable but relationships require years of consistent cultivation to convert.
What Customers Say
We were spending 3 hours a day on list building. Strides does it overnight while we sleep. We wake up to 200 verified, signal-qualified leads every morning.
Daniel Frey, Head of Sales at Paigo — 200 signal-qualified leads delivered every morning
Our previous tool sent the same email with the name swapped. Strides writes something different for every single person. Prospects actually respond saying they were impressed.
Jordan Lee, Director of Sales at Resend — Reply rate up 3.7× in the first 30 days
Related
- For Biotech — Autonomous outbound for biotech and life sciences companies.
- For Healthcare — AI outbound for healthcare and clinical organizations.
- AI BDR — The complete autonomous BDR — from research to booked meeting.
Frequently Asked Questions
What pharma signals does Strides monitor?
FDA approval events, IND and NDA filings, Phase transition announcements on ClinicalTrials.gov, manufacturing capacity announcements, pharma M&A events, pipeline expansion disclosures, and pharma technology procurement signals in job postings.
Can Strides reach procurement, R&D, and commercial pharma decision-makers?
Yes. Strides identifies VP R&D, Head of Procurement, Clinical Operations Directors, VP Commercial, and Medical Affairs leads at pharma companies with messaging calibrated to their specific function and pipeline stage.
Does Strides work for CROs, CDMOs, and pharma technology vendors?
Yes. CROs and CDMOs use Strides to reach pharma and biotech companies at the right pipeline stage. Pharma technology vendors use it to reach the technology decision-makers across large pharma and emerging biotech.
How does Strides handle the regulatory sensitivity of pharmaceutical sales?
Strides sends B2B commercial outreach to pharmaceutical procurement and business decision-makers — not clinical or medical communications. The messaging is professional and operations-focused, fully appropriate for vendor-to-buyer communication.
Can Strides support both large pharma and emerging biotech company targeting?
Yes with different configurations. Large pharma requires targeting procurement and vendor management functions. Emerging biotech requires reaching founders and COOs directly. Strides manages both with distinct ICPs and messaging.